| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Natera, Inc. | $281.27 | -0.9% | $40.28B | -185.0 | -10.9% | — | Healthcare | 77.2% | 36.6% | ||
| 2 | Guardant Health, Inc. | $162.92 | -3.5% | $21.6B | -49.1 | 0% | — | Healthcare | 228.9% | 39.6% | ||
| 3 | Exact Sciences Corporation | $104.91 | 0% | $20.02B | -95.4 | 80.3% | — | Healthcare | 99.9% | 17.7% | ||
| 4 | GRAIL, Inc. | $68.79 | -0.2% | $2.82B | -6.2 | 83% | — | Healthcare | 53.4% | 19.4% | ||
| 5 | CareDx, Inc | $28.31 | -2.6% | $1.46B | -70.8 | -114.6% | — | Healthcare | 53.4% | 19.2% | ||
| 6 | Personalis, Inc. | $13.98 | -2.5% | $1.24B | -15.4 | 20.9% | — | Healthcare | 109.3% | -24.7% | ||
| 7 | Castle Biosciences, Inc. | $23.83 | -1.6% | $723M | -28.7 | -126.5% | — | Healthcare | 22.5% | -2.1% | ||
| 8 | Fulgent Genetics, Inc. | $21.02 | -1.7% | $597M | -10.7 | -78.9% | — | Healthcare | 9% | 9.5% | ||
| 9 | Myriad Genetics, Inc. | $5.86 | -2.8% | $548M | -1.5 | -284% | — | Healthcare | 10.8% | -0.3% | ||
| 10 | Biodesix, Inc. | $20.34 | -6.9% | $154M | -4.4 | 30% | — | Healthcare | 268.5% | 29.1% | ||
| 11 | Sera Prognostics, Inc. | $2.01 | -3.8% | $77M | -3.0 | 30.9% | — | Healthcare | -16.9% | -50.4% | ||
| 12 | Precipio, Inc. | $26.00 | 2.9% | $45M | -8.9 | 59% | — | Healthcare | 86% | 23.6% | ||
| 13 | MDxHealth S.A. | $0.47 | -3% | $24M | -0.7 | 67.2% | — | Healthcare | -78.1% | 59.7% | ||
| 14 | Burning Rock Biotech Limited | $10.75 | 4% | $11M | -1.5 | 84.6% | — | Healthcare | 201.8% | 4.6% | ||
| 15 | VolitionRx Limited | $1.40 | 3.7% | $7M | -0.3 | 22.2% | — | Healthcare | -89.6% | 88.5% | ||
| 16 | BioNexus Gene Lab Corp. | $1.91 | -9% | $4M | -1.2 | -25.4% | — | Healthcare | -67.8% | -42.7% | ||
| 17 | bioAffinity Technologies, Inc. | $0.83 | 2.7% | $4M | -0.1 | 41.6% | — | Healthcare | -90.6% | -35.8% | ||
| 18 | Mainz Biomed B.V. | $3.59 | 412.9% | $3M | -0.2 | -1156.1% | — | Healthcare | 156.4% | 45.3% |